Case-ControlStrong Evidence2020

Landmark study identified vitamin E acetate as the primary toxicant behind the 2019 vaping lung injury outbreak

Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.

Blount, Benjamin C; Karwowski, Mateusz P; Shields, Peter G; Morel-Espinosa, Maria; Valentin-Blasini, Liza; Gardner, Michael; Braselton, Martha; Brosius, Christina R; Caron, Kevin T; Chambers, David; Corstvet, Joseph; Cowan, Elizabeth; De Jesús, Víctor R; Espinosa, Paul; Fernandez, Carolina; Holder, Cory; Kuklenyik, Zsuzsanna; Kusovschi, Jennifer D; Newman, Cody; Reis, Gregory B; Rees, Jon; Reese, Chris; Silva, Lalith; Seyler, Tiffany; Song, Min-Ae; Sosnoff, Connie; Spitzer, Carleen R; Tevis, Denise; Wang, Lanqing; Watson, Cliff; Wewers, Mark D; Xia, Baoyun; Heitkemper, Douglas T; Ghinai, Isaac; Layden, Jennifer; Briss, Peter; King, Brian A; Delaney, Lisa J; Jones, Christopher M; Baldwin, Grant T; Patel, Anita; Meaney-Delman, Dana; Rose, Dale; Krishnasamy, Vikram; Barr, John R; Thomas, Jerry; Pirkle, James L·The New England journal of medicine·PubMed

Bottom Line

Vitamin E acetate was found in the lung fluid of 94% of EVALI patients but in none of the healthy comparators, establishing it as the strongest chemical link to the 2019 vaping illness outbreak.

Why It Matters

This NEJM study provided the strongest direct evidence linking vitamin E acetate to the EVALI outbreak, helping public health authorities identify the cause and issue targeted warnings about illicit THC vaping products.

The Backstory

In the summer of 2019, previously healthy teenagers and young adults began showing up in emergency departments across the United States with a terrifying constellation of symptoms: shortness of breath, chest pain, nausea, vomiting, and fever. Chest X-rays showed widespread lung infiltrates — the kind of damage usually seen in severe pneumonia or chemical exposure. But cultures were negative. These patients did not have infections.

Within weeks, they were on ventilators. Within months, they were dying.

By the time the CDC stopped counting in February 2020, the epidemic had hospitalized 2,807 people in all 50 states and killed 68 — many of them in their twenties and thirties. The cause was something no physician had been trained to look for: a lipid thickening agent called vitamin E acetate, used to dilute black-market THC vape cartridges.

The Investigation

Benjamin Blount and a massive team of CDC, FDA, and state health department scientists conducted the study that cracked the case. It was published in the New England Journal of Medicine — the most prestigious medical journal in the world — and it provided the direct evidence linking vitamin E acetate to the lung injury.

The methodological choice was critical. Instead of testing the vape products themselves — which would only show what was in the cartridge, not what reached the lungs — the investigators tested bronchoalveolar lavage (BAL) fluid: the liquid washed directly from patients' damaged lungs. This provided direct evidence of what was actually present at the site of injury.

They tested for six priority toxicant categories: vitamin E acetate, plant oils, medium-chain triglyceride (MCT) oil, coconut oil, petroleum distillates, and diluent terpenes.

The Results

94%

of EVALI patients (48 of 51) had vitamin E acetate detected in their bronchoalveolar lavage fluid. Zero of 99 healthy controls had any detectable vitamin E acetate.

No other priority toxicant was found in the case patients — except coconut oil and limonene in one patient each. This was not a cocktail of contaminants. It was one substance, overwhelmingly present in cases and completely absent in controls.

Blount et al. (2020), N Engl J Med

The specificity was remarkable. Vitamin E acetate was present in nearly every EVALI patient and absent in every healthy comparator — including the comparators who vaped nicotine products or smoked cigarettes. The signal was as clear as epidemiological evidence gets.

What Is Vitamin E Acetate and Why Was It There?

The cruelty of the mechanism is that vitamin E acetate is genuinely safe in every other context. You can eat it. You can rub it on your skin. It is in thousands of consumer products. But the lungs are not the skin. The alveolar membrane is one cell thick. What is harmless elsewhere is catastrophic when aerosolized and inhaled into the deepest reaches of the respiratory system.

The Timeline of a Public Health Crisis

The Tragedy of Prohibition

EVALI was not a failure of cannabis. It was a failure of cannabis policy.

Vitamin E acetate was never used in legal, regulated THC vape products. State-licensed cannabis manufacturers are required to test their products and have no economic incentive to dilute them — their products are tested, labeled, and traceable. The adulteration occurred exclusively in the black market, where unregulated producers cut THC oil with a cheap thickener to maximize profit with no quality oversight.

Myth vs. Reality

Myth

Vaping cannabis is inherently dangerous because of EVALI

Reality

EVALI was caused by vitamin E acetate, a specific adulterant found almost exclusively in black-market THC vape cartridges. Legal, tested cannabis vape products were not implicated. The lesson is not that cannabis vaping is dangerous — it is that unregulated cannabis markets are dangerous. Every death from EVALI was a death caused by prohibition's unintended consequences.

The Evidence

Blount et al. (2020): 94% of EVALI patients used THC products, and vitamin E acetate was the identified toxicant

This framing is not pro-cannabis advocacy. It is the direct conclusion of the public health evidence. The CDC's own investigation found that the outbreak was driven by illicit products in an unregulated market. States with legal cannabis markets saw lower rates of EVALI. The epidemic disproportionately affected communities where legal access was unavailable and black-market products filled the gap.

What People Get Wrong

The collateral damage from EVALI extended far beyond the direct victims. The initial public health messaging — "stop vaping" without distinction between THC and nicotine products — caused panic among nicotine vapers who were using a regulated harm reduction tool to quit cigarettes. Some returned to smoking, arguably increasing their long-term health risk. The confusion persists: surveys show that many Americans still believe that all vaping is equally dangerous, conflating black-market THC cartridges with FDA-regulated nicotine products.

For cannabis users, the lasting lesson is simpler: know what is in your vape. If you cannot verify the source, the testing, and the contents, you are gambling with your lungs. Our vape safety guide covers how to identify regulated products and what to avoid.

Frequently Asked Questions

Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI

Blount BC, Karwowski MP, Shields PG, et al. () · New England Journal of Medicine

Cite this study

Blount, Benjamin C; Karwowski, Mateusz P; Shields, Peter G; Morel-Espinosa, Maria; Valentin-Blasini, Liza; Gardner, Michael; Braselton, Martha; Brosius, Christina R; Caron, Kevin T; Chambers, David; Corstvet, Joseph; Cowan, Elizabeth; De Jesús, Víctor R; Espinosa, Paul; Fernandez, Carolina; Holder, Cory; Kuklenyik, Zsuzsanna; Kusovschi, Jennifer D; Newman, Cody; Reis, Gregory B; Rees, Jon; Reese, Chris; Silva, Lalith; Seyler, Tiffany; Song, Min-Ae; Sosnoff, Connie; Spitzer, Carleen R; Tevis, Denise; Wang, Lanqing; Watson, Cliff; Wewers, Mark D; Xia, Baoyun; Heitkemper, Douglas T; Ghinai, Isaac; Layden, Jennifer; Briss, Peter; King, Brian A; Delaney, Lisa J; Jones, Christopher M; Baldwin, Grant T; Patel, Anita; Meaney-Delman, Dana; Rose, Dale; Krishnasamy, Vikram; Barr, John R; Thomas, Jerry; Pirkle, James L. (2020). Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.. The New England journal of medicine, 382(8), 697-705. https://doi.org/10.1056/NEJMoa1916433

Related Research

RTHC-02135Cross SectionalModerate Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-07209ReviewModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-00034Case ReportPreliminary Evidence1986RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-00207ReviewModerate Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research